Search
Celldex Therapeutics Inc
CLDXAdd to Watchlist
38.060USD
-0.425-1.10%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.99BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Celldex Therapeutics Inc is 8.50, ranking 108 out of 385 in the Biotechnology & Medical Research industry. The average price target is 53.00, with a high of 90.00 and a low of 21.00.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
57.067
Target Price
+52.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Celldex Therapeutics Inc
CLDX
16
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Celldex Therapeutics Inc's expected revenue for the next quarter?
Celldex Therapeutics Inc's expected revenue is 954.44K.
What is Celldex Therapeutics Inc's price target?
Analysts forecast that Celldex Therapeutics Inc's price target is USD 53.00, with the highest forecast at USD 90.00 and the lowest forecast at USD 21.00.
How have Celldex Therapeutics IncCLDX's recent earnings per share performed?
The market expectation was USD -1.18, while Celldex Therapeutics IncCLDX's earnings per share (EPS) for the previous quarter was USD -1.22. EPS for the next quarter is expected at USD -1.06.
What is the analyst rating for Celldex Therapeutics Inc?
Based on the ratings of Celldex Therapeutics Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.